The Efficacy and Safety of REX-001 to Treat Ischemic Rest Pain in Subjects With CLI Rutherford Category 4 and DM

NCT03111238 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

3

Enrollment

INDUSTRY

Sponsor class

Stopped Stopped due to inactivity

Conditions

Peripheral Arterial Disease (PAD)
Diabetes Mellitus (DM)
Diabetes Mellitus, Type 1
Diabetes Mellitus, Type 2
Cardiovascular Disease
Critical Limb Ischemia (CLI)

Interventions

DRUG: REX-001
DRUG: Placebo

Sponsor

Ixaka Ltd

Collaborators

[object Object]